Advertisement
Research Article|Articles in Press, 103650

Blood donor notification rate in a blood bank in Veracruz, Mexico

Published:February 03, 2023DOI:https://doi.org/10.1016/j.transci.2023.103650
Blood donor notification rate in a blood bank in Veracruz, Mexico
Previous ArticleThe Italian registry of therapeutic apheresis: year of activity 2021
Next ArticleDemographics and appropriateness of cellular blood component irradiation practices: Ambispective analysis from a tertiary care center

      Abstract

      Blood banks are primarily responsible for providing safe blood, but they also indirectly act to prevent the spread of infectious diseases by notifying blood donors of positive screening results. The notification process differs between countries and notifications rates are generally low. This study sought to analyze the notification rate of healthy and infection-positive donors who donated blood at CETS-Veracruz. A total of 41790 donors were analyzed, 1585 (3.79%) were positive for one or more of the screened infection markers. Only 4163 (9.96% of the total) were notified about their serology results. Of the positive donors, 157 were contacted by phone call; of them, 91 (57%) returned to the blood bank for their results. The average notification rate for positive donors was only 17.48%. The highest notification rate was for anti-HBc (26.63%), while the lowest was for HBsAg (4.17%). Age significantly influenced the return of donors: Those aged 18–24 and 25–39 years were 4.71 and 1.64 times less likely, respectively, to return for their results compared to the rate for all ages. The advice received in the pre-donation stage about the risks of transfusion-transmitted infections and the relevance of returning for results did not appear to impact donors, since the rate of notification was lower than those reported internationally. These data indicate that CETS-Veracruz should improve donor data registration and communication mechanisms to increase the notification rate, and that donor notification studies should be carried out in other Mexican blood banks to analyze the return rate at the national level.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Kaur G.
        • et al.
        Donor notification and counseling--experience and challenges.
        Transfus Apher Sci. 2013; 49: 291-294https://doi.org/10.1016/j.transci.2013.05.005
        View in Article
        • Hernandez-Romano P.A.
        • et al.
        First approach in the implementation of the nucleic acid amplification test in a resource-limited blood bank in Mexico.
        Transfus Med. 2017; 27: 75-77https://doi.org/10.1111/tme.12383
        View in Article
        • Hernandez-Romano P.
        • et al.
        Occult hepatitis B infections and anti-HBc prevalence at a resource-limited blood bank in Mexico.
        Transfus Med. 2020; 30: 396-400https://doi.org/10.1111/tme.12681
        View in Article

      4. Secretaría de Salud. Norma Oficial Mexicana NOM-253-SSA1–2012. Para la disposición de sangre humana y sus componentes con fines terapéuticos. 2012. Aviable from: https://www.gob.mx/cnts/documentos/norma-oficial-mexicana-nom-253-ssa1–2012-para-la-disposicion-de-sangre-humana-y-sus-componentes-con-fines-terapeuticos.

        View in Article
        • Medina J.R.
        Enfermedades infecciosas transmitidas por transfusión. Panorama internacional y en México.
        Gac Médica De México. 2014; 150 (DOI: https://www.medigraphic.com/pdfs/gaceta/gm-2014/gm141j.pdf): 78-83
        View in Article
        • World Health Organization
        Blood Donor Couns: Implement Guidel. 2023; (Available from): 2014
        〈https://www.ncbi.nlm.nih.gov/books/NBK310580/pdf/Bookshelf_NBK310580.pdf〉
        View in Article

      7. World Health Organization. Fact Sheets: Blood safety and availability 2022. 2022; Available from: https://www.who.int/news-room/fact-sheets/detail/blood-safety-and-availability.

        View in Article
        • Shivaram Chandrashekar A.K.
        Blood donor notification: Boon for the community, bane for blood donors, and blood centers?.
        Glob. J. Trans.Med. 2018; 3 (DOI: https://www.gjtmonline.com/text.asp?2018/3/1/6/229327): 6-12
        View in Article
        • Reynolds C.A.
        • Brailsford S.R.
        • Hewitt P.E.
        Notifying blood donors of infection: results of a donor satisfaction survey.
        Transfus Med. 2015; 25: 358-365https://doi.org/10.1111/tme.12268
        View in Article
        • Kotwal U.
        • et al.
        Blood donor notification and counseling: our experience from a tertiary care hospital in India.
        Asian J Transfus Sci. 2015; 9: 18-22https://doi.org/10.4103/0973-6247.150941
        View in Article
        • Porto-Ferreira F.A.
        • et al.
        A randomized trial to evaluate the use of text messaging, letter, and telephone call reminders to improve return of blood donors with reactive serologic tests.
        Transfusion. 2017; 57: 102-107https://doi.org/10.1111/trf.13882
        View in Article
        • Hernandez-Romano P.
        • et al.
        Prevalence of Trypanosoma cruzi antibodies in blood donors from Veracruz State, Mexico.
        Transfusion. 2015; 55: 647-656https://doi.org/10.1111/trf.12860
        View in Article
        • Lopez-Balderas N.
        • et al.
        Trends in prevalence of HIV and syphilis in a central blood bank of Veracruz, Mexico.
        Transfus Apher Sci. 2019; 58: 94-99https://doi.org/10.1016/j.transci.2018.12.001
        View in Article
        • Anjali Handa N.K.
        • Aggarwal Deepika
        • Maharishi Ram N.
        Donor notification and response rate of sero-reactive blood donors: a challenge and long way to go.
        Int J Community Medicine Public Health. 2019; 6: 2794-2797https://doi.org/10.18203/2394-6040.ijcmph20192596
        View in Article

      15. Secretaría de Salud. SISTEMA DE VIGILANCIA EPIDEMIOLÓGICA DE VIH INFORME HISTÓRICO DE VIH 4TO TRIMESTRE 2021. 2021; Available from: https://www.gob.mx/cms/uploads/attachment/file/710892/VIH-SIDA_4totrim_2021.pdf.

        View in Article

      16. Secretaría de Salud. Informe Anual de Vigilancia Epidemiológica de Hepatitis Virales, México 2020. 2020; Available from: https://www.gob.mx/salud/documentos/informes-sistema-de-vigilancia-epidemiologica-de-las-hepatitis-virales.

        View in Article
        • Raza N.
        • Qureshi H.
        • Qureshi A.
        Reactive blood donor notification; their responses and perceptions: experience From Southern Pakistan.
        J Ayub Med Coll Abbottabad. 2018; 30: 351-355
        View in Article

      18. World Health Organization. Hepatitis B. 2022; Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.

        View in Article

      19. World Health Organization. Hepatitis C. 2022; Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c.

        View in Article

      20. World Health Organization. Sexually transmitted infections (STIs). 2022; Available from: https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis).

        View in Article

      21. Secretaría de Salud. Boletín de Atención Integral de Personas que Viven con VIH. 2021; Available from: https://www.gob.mx/cms/uploads/attachment/file/684194/BAI_DAI_2021_4.pdf.

        View in Article

      22. World Health Organization. Chagas disease (Amrican trypanosomoiasis). 2022; Available from: https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis).

        View in Article

      Article info

      Publication history

      Published online: February 03, 2023
      Accepted: January 30, 2023
      Received in revised form: January 18, 2023
      Received: October 11, 2022

      Publication stage

      In Press Journal Pre-Proof

      Identification

      DOI: https://doi.org/10.1016/j.transci.2023.103650

      Copyright

      © 2023 Elsevier Ltd. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX